BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 9249283)

  • 21. Oral hyposensitization to poison ivy and poison oak.
    Marks JG; Trautlein JJ; Epstein WL; Laws DM; Sicard GR
    Arch Dermatol; 1987 Apr; 123(4):476-8. PubMed ID: 2950827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plant Dermatitis: More Than Just Poison Ivy.
    Watchmaker L; Reeder M; Atwater AR
    Cutis; 2021 Sep; 108(3):124-127. PubMed ID: 34826273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
    Walker LA; Watson ES; elSohly MA
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sesquiterpene lactone mix patch testing supplemented with dandelion extract in patients with allergic contact dermatitis, atopic dermatitis and non-allergic chronic inflammatory skin diseases.
    Jovanović M; Poljacki M; Mimica-Dukić N; Boza P; Vujanović Lj; Duran V; Stojanović S
    Contact Dermatitis; 2004 Sep; 51(3):101-10. PubMed ID: 15479198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poison ivy/oak dermatitis. Part I: Prevention--soap and water, topical barriers, hyposensitization.
    Fisher AA
    Cutis; 1996 Jun; 57(6):384-6. PubMed ID: 8804839
    [No Abstract]   [Full Text] [Related]  

  • 26. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.
    Kalish RS; Johnson KL
    J Immunol; 1990 Dec; 145(11):3706-13. PubMed ID: 2147199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?
    Kim Y; Flamm A; ElSohly MA; Kaplan DH; Hage RJ; Hamann CP; Marks JG
    Dermatitis; 2019; 30(3):183-190. PubMed ID: 31045932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contact allergy to Anacardiaceae. A review and case reports of poison ivy allergy in central Europe].
    Ippen H
    Derm Beruf Umwelt; 1983; 31(5):140-8. PubMed ID: 6227468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urushiol detection using a profluorescent nitroxide.
    Braslau R; Rivera F; Lilie E; Cottman M
    J Org Chem; 2013 Jan; 78(2):238-45. PubMed ID: 22900824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed contact sensitivity to catechols. 3. The relationship of side-chain length to sensitizing potency of catechols chemically related to the active principles of poison ivy.
    Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
    J Immunol; 1967 Aug; 99(2):370-5. PubMed ID: 4226616
    [No Abstract]   [Full Text] [Related]  

  • 33. Jewelweed treatment of poison ivy dermatitis.
    Guin JD; Reynolds R
    Contact Dermatitis; 1980 Jun; 6(4):287-8. PubMed ID: 6447037
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of experimentally induced irritant contact dermatitis by extracts of Isatis tinctoria compared to pure tryptanthrin and its impact on UVB-induced erythema.
    Heinemann C; Schliemann-Willers S; Oberthür C; Hamburger M; Elsner P
    Planta Med; 2004 May; 70(5):385-90. PubMed ID: 15124080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of poison oak dermatitis treated with Grindelia spp. (Gumweed).
    Canavan D; Yarnell E
    J Altern Complement Med; 2005 Aug; 11(4):709-10. PubMed ID: 16131296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resorcinols and catechols: a clinical study of cross-sensitivity.
    Knight TE; Boll P; Epstein WL; Prasad AK
    Am J Contact Dermat; 1996 Sep; 7(3):138-45. PubMed ID: 8957327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of toxicodendron dermatitis (poison ivy and poison oak).
    Guin JD
    Skin Therapy Lett; 2001 Apr; 6(7):3-5. PubMed ID: 11376396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Algerian ivy dermatitis; a California disease.
    DORSEY CS
    Calif Med; 1959 Feb; 90(2):155-9. PubMed ID: 13629356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy.
    Liu B; Tai Y; Achanta S; Kaelberer MM; Caceres AI; Shao X; Fang J; Jordt SE
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7572-E7579. PubMed ID: 27821781
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.